【新型コロナ】「アビガン」明確な有効性確認できず 藤田医大など ★２ [しじみ★]

137 ：名無しのひみつ：2020/08/10(月) 21:16:59 ID:NIVl6Pdw.net

>>136
In May 2020 the Russian Ministry of Health granted fast-track marketing authorization to RNA polymerase inhibitor AVIFAVIR (favipiravir) for the treatment of COVID-19 patients.
In the pilot stage of Phase II/III clinical trial, AVIFAVIR enabled SARS-CoV-2 viral clearance in 62.5% of patients within 4 days, and was safe and well-tolerated.

ロシアアビガン投与4日目は62.5%